https://www.selleckchem.com/products/h3b-120.html
To evaluate the extent to which internationally agreed treat-to-target (T2T) recommendations were applied in clinical practice in patients with axial spondyloarthritis (axSpA). Data were used from a web-based patient registry for monitoring SpA in daily practice in the Netherlands (SpA-Net). The extent to which T2T was applied was evaluated through four indicators the proportion of patients 1) with ≥1 Ankylosing Spondylitis Disease Activity Score (ASDAS) assessed during a 1-year period, 2) having inactive disease/low disease activity (I